Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

Objective: to assess the efficacy of anti-angiogenic agents incorporated into second-line chemotherapeutic regimens for metastatic colon cancer depending on the KRAS gene mutation status.Materials and methods. We selected completed prospective randomized controlled phase III clinical trials evaluati...

Full description

Bibliographic Details
Main Authors: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2018-07-01
Series:Тазовая хирургия и онкология
Subjects:
colon cancer
anti-angiogenic therapy
chemotherapy
randomized trials
meta-analysis
mutation in the kras gene
Online Access:https://ok.abvpress.ru/jour/article/view/249

Internet

https://ok.abvpress.ru/jour/article/view/249

Similar Items